SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients
SARS-CoV-2 성장, 퓨린 절단 부위 적응 및 급성 감염 입원 COVID-19 환자의 혈청을 사용한 중화
Research Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
adaptation
angiotensin
antigenic target
Betacoronavirus
both viruses
causative agent
caused
Cell
cell lysate
cell surface
cells
characterized
cleavage
clinical isolates
comparable
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
deaths
deleted
Deletion
demonstrated
disease
expand
furin
furin cleavage
generate
glycoprotein
growth
hACE2
Healthcare system
Healthcare systems
hospitalized COVID-19 patient
host range
human Angiotensin-converting enzyme
Human angiotensin-converting enzyme 2
in vitro
in vivo
indirect immunofluorescence
inefficient
Infection
insertion
investigated
Like
MinION
Munich
neutralization
Neutralizing antibodies
neutralizing antibody titre
neutralizing antibody titres
Pathogenesis
patients
reached
receptor
respiratory
S glycoprotein
S protein
SARS-CoV
SARS-CoV-2
SARS-CoV-2 spike
Sequencing
serum
serum sample
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
spread to
strain
the cell
the S protein
the SARS-CoV-2
variant
Vero E6
Vero E6 cell
VERO E6 cells
virus
virus stock
virus stocks
viruses
[DOI] 10.1099/jgv.0.001481 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1099/jgv.0.001481 PMC 바로가기 [Article Type] Research Article